Edap Tms SA
EDAP4.730USD
+0.730+18.25%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
176.86MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Edap Tms SA Unternehmen
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Edap Tms SA Informationen
BörsenkürzelEDAP
Name des UnternehmensEdap Tms SA
IPO-datumAug 01, 1997
CEORhodes (Ryan)
Anzahl der mitarbeiter310
WertpapierartDepository Receipt
GeschäftsjahresendeAug 01
Addresse4, rue du Dauphine
StadtVAULX-EN-VELIN
BörseNASDAQ OMX - NASDAQ BASIC
LandFrance
Postleitzahl69120
Telefon33472153150
Websitehttps://focalone.com/fr/accueil/
BörsenkürzelEDAP
IPO-datumAug 01, 1997
CEORhodes (Ryan)
Führungskräfte von Edap Tms SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.24M
+1241780.00%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
301.15K
+301149.00%
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Ms. Blandine Confort
Ms. Blandine Confort
Investor Relations Officer, Director - Legal Affairs
Investor Relations Officer, Director - Legal Affairs
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Ken Mobeck
Mr. Ken Mobeck
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
--
--
Mr. Glen French
Mr. Glen French
Independent Director
Independent Director
--
--
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.24M
+1241780.00%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
301.15K
+301149.00%
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Ms. Blandine Confort
Ms. Blandine Confort
Investor Relations Officer, Director - Legal Affairs
Investor Relations Officer, Director - Legal Affairs
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
Asia
19.04M
29.70%
United States
18.22M
28.42%
Other Geographical Areas
15.61M
24.35%
France
11.24M
17.53%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: 6 hours ago
Aktualisiert: 6 hours ago
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
8.99%
Rock Springs Capital Management LP
3.40%
Willsey (Lance)
3.32%
Bruce & Company, Inc.
1.17%
Andere
63.57%
Aktionäre
Aktionäre
Anteil
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
8.99%
Rock Springs Capital Management LP
3.40%
Willsey (Lance)
3.32%
Bruce & Company, Inc.
1.17%
Andere
63.57%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
23.94%
Research Firm
9.07%
Individual Investor
4.42%
Investment Advisor
3.89%
Investment Advisor/Hedge Fund
0.23%
Bank and Trust
0.01%
Andere
58.44%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
67
13.87M
40.98%
--
2025Q3
75
13.87M
43.87%
-275.79K
2025Q2
87
14.15M
45.65%
-604.14K
2025Q1
89
14.75M
47.73%
-3.10M
2024Q4
92
15.39M
47.99%
-286.99K
2024Q3
91
15.67M
50.30%
-364.48K
2024Q2
88
16.06M
51.11%
-201.29K
2024Q1
93
16.22M
51.99%
-3.07M
2023Q4
90
15.98M
53.82%
-494.00
2023Q3
93
15.98M
53.21%
-272.41K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Soleus Capital Management, L.P.
7.31M
19.55%
--
--
Sep 30, 2025
Morgan Stanley & Co. International Plc
3.36M
8.99%
-800.00
-0.02%
Sep 30, 2025
Rock Springs Capital Management LP
1.27M
3.4%
--
--
Sep 30, 2025
Bruce & Company, Inc.
438.65K
1.17%
-115.00K
-20.77%
Sep 30, 2025
UBS Financial Services, Inc.
234.44K
0.63%
+59.77K
+34.22%
Sep 30, 2025
Schonfeld Strategic Advisors LLC
170.06K
0.45%
-2.08K
-1.21%
Sep 30, 2025
Parkman Healthcare Partners LLC
154.83K
0.41%
--
--
Sep 30, 2025
Cahill Financial Advisors, Inc.
134.96K
0.36%
--
--
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
ActivePassive International Equity ETF
0%
ActivePassive International Equity ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
